Coloplast
-5.92%

Healthcare & biotech / Medical devices and services

🚀 Founded 1957 🌎 Denmark 🏷️ CLPBY DK0060448595 ⭐ 1000 DCF 1.06 💰9.05

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights (3) 🏢 Company Q&A (465) 🛠️ Industry Q&A (98) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

⚖️ Balance Sheet 💵 Income Statement 🔄 Cash Flow 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

📢 Press Releases

[ Disclaimer ]

Date	Press release
2025-05-05 11:11:00	Coloplast A/s Ceo Kristian Villumsen Steps Down As Of Today Coloplast ceo kristian villumsen steps down from his ceo position as of today. the board of directors has asked lars rasmussen to step in as interim ceo.
2025-02-04 08:27:00	Coloplast Finance B.v. - Interim Financial Report, Q1 2024/25 2024/25 interim financial results, q1 2024/25 1 october 2024 - 31 december 2024 coloplast delivered 8% organic growth and an ebit margin1 of 27% in q1, in line with expectations. reported revenue in dkk grew 6% and included negative impact from the divestment of skin care and currencies.
2025-02-04 07:12:00	Coloplast A/s - Allocation Of Share Options Report on transactions of executives and related parties in coloplast shares and related securities according to the market abuse regulation article 19 coloplast is obliged to report on the transactions of executives and their related parties in coloplast shares and related securities. the below transactions concern allocation of share options.
2025-01-21 09:08:00	Coloplast A/s - Q1 2024/25 Earnings Release - Invitation To Conference Call On 4 February 2025 At 11.00am Cet Tuesday, 4 february 2025 at 10.00 - 11.00am cet in connection with the publication of coloplast’s interim financial results for q1 2024/25, to be released same day around 07.30am cet, coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. a presentation will be available on coloplast’s website approximately 1 hour before the conference call.the webcast of the conference call will be available during and after the event.
2024-12-11 09:54:00	Coloplast A/s - Trading In Coloplast Shares By Board Members, Executives Or Associated Persons Coloplast a/s - trading in coloplast shares by board members, executives or associated persons.
2024-12-05 11:11:00	Q29sb3BsYX N0IEEvcyAt IERlY2lzaW 9ucyBBdCBU aGUgQW5udW FsIEdlbmVy YWwgTWVldG luZyAyMDI0 VG9kYXksID UgZGVjZW1i ZXIgMjAyNC wgY29sb3Bs YXN0IGEvcy BoZWxkIGl0 cyBhbm51YW wgZ2VuZXJh bCBtZWV0aW 5nLCBhdCB3 aGljaCB0aG UgZm9sbG93 aW5nIHJlc2 9sdXRpb25z IHdlcmUgYW RvcHRlZDog dGhlIGFubn VhbCByZXBv cnQgZm9yIH RoZSBmaW5h bmNpYWwgeW VhciAyMDIz LzI0IHdhcy BhcHByb3Zl ZC4gZGlzdH JpYnV0aW9u IG9mIHllYX ItZW5kIGRp dmlkZW5kIG 9mIGRrayAx Ny4wMCBwZX Igc2hhcmUg b2Ygbm9taW 5hbGx5IGRr ayAxIHdhcy BhcHByb3Zl ZC4=
2024-10-21 09:09:00	Q29sb3BsYX N0IEEvcyAt IEZ5IDIwMj MvMjQgRWFy bmluZ3MgUm VsZWFzZSAt IEludml0YX Rpb24gRm9y IENvbmZlcm VuY2UgQ2Fs bCBPbiA1IE 5vdmVtYmVy IDIwMjQgQX QgMTEuMDAg Q2V0 VHVlc2RheS wgNSBub3Zl bWJlciAyMD I0IGF0IDEx LjAwIOKAky AxMi4wMCBj ZXQgaW4gY2 9ubmVjdGlv biB3aXRoIH RoZSBwdWJs aWNhdGlvbi BvZiBjb2xv cGxhc3TigJ lzIGludGVy aW0gZmluYW 5jaWFsIHJl c3VsdHMgZm 9yIGZ5IDIw MjMvMjQgdG hlIGNvbXBh bnkgd2lsbC Bob3N0IGEg Y29uZmVyZW 5jZSBjYWxs IHRvIHByZX NlbnQgdGhl IGZpbmFuY2 lhbMKgcmVz dWx0cyBhbm QgYW5zd2Vy IHF1ZXN0aW 9ucyBmcm9t IGludmVzdG 9ycyBhbmQg ZmluYW5jaW FsIGFuYWx5 c3RzLmEgcH Jlc2VudGF0 aW9uIHdpbG wgYmUgYXZh aWxhYmxlIG 9uIGNvbG9w bGFzdOKAmX Mgd2Vic2l0 ZSBhcHByb3 hpbWF0ZWx5 IDEgaG91ci BiZWZvcmUg dGhlIGNvbm ZlcmVuY2Ug Y2FsbC5wbG Vhc2Ugbm90 ZSB0aGF0IH RoZSB3ZWJj YXN0IG9mIH RoZSBjb25m ZXJlbmNlIG NhbGwgd2ls bCBiZSBhdm FpbGFibGUg ZHVyaW5nIG FuZCBhZnRl ciB0aGUgZX ZlbnQu
2024-09-25 09:02:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== UGxlYXNlIH NlZSBlbmNs b3NlZCBwZG YuIMKgIGF0 dGFjaG1lbn QgMjUwOTIw MjRfdHJhZG luZ19pbl9z aGFyZXNfbl 9wX2xvdWlz LWhhbnNlbl 9hcHM=
2024-09-25 08:29:00	Q29sb3BsYX N0IEEvcyAt IEZpbmFuY2 lhbCBDYWxl bmRhciAyMD I0LTI1 UGxlYXNlIH NlZSBlbmNs b3NlZCBwZG YuIGZvciBt b3JlIGluZm 9ybWF0aW9u IGFuZCBjYW xlbmRhciBp bnZpdGF0aW 9ucyBmb3Ig dXBjb21pbm cgZXZlbnRz LCBwbGVhc2 UgdmlzaXQ6 wqBodHRwcz ovL2ludmVz dG9yLmNvbG 9wbGFzdC5j b20vaW52ZX N0b3ItcmVs YXRpb25zL2 ZpbmFuY2lh bC1jYWxlbm Rhci1hbmQt ZXZlbnRzLy BraW5kIHJl Z2FyZHMsaW 52ZXN0b3Ig cmVsYXRpb2 5zY29sb3Bs YXN0IGEvc3 RlbC4=
2024-09-03 09:20:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== UGxlYXNlIH NlZSBlbmNs b3NlZCBwZG YuIMKgIGF0 dGFjaG1lbn QgMDMwOTIw MjRfdHJhZG luZ19pbl9z aGFyZXNfYX Ns
2024-09-03 09:03:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== UGxlYXNlIH NlZSBlbmNs b3NlZCBwZG YuIMKgIGF0 dGFjaG1lbn QgMDMwOTIw MjRfdHJhZG luZ19pbl9z aGFyZXNfbm Fu
2024-08-30 11:07:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== Q29sb3BsYX N0IGEvcyAt IHRyYWRpbm cgaW4gY29s b3BsYXN0IH NoYXJlcyBi eSBib2FyZC BtZW1iZXJz LCBleGVjdX RpdmVzIG9y IGFzc29jaW F0ZWQgcGVy c29ucy4=
2024-08-30 10:02:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== Q29sb3BsYX N0IGEvcyAt IHRyYWRpbm cgaW4gY29s b3BsYXN0IH NoYXJlcyBi eSBib2FyZC BtZW1iZXJz LCBleGVjdX RpdmVzIG9y IGFzc29jaW F0ZWQgcGVy c29ucy4=
2024-03-08 08:43:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== UGxlYXNlIH NlZSBlbmNs b3NlZCBwZG YuIGF0dGFj aG1lbnQgMD gwMzIwMjRf dHJhZGluZ1 9pbl9zaGFy ZXNfbHJh
2024-03-06 08:50:00	Q29sb3BsYX N0IEEvcyAt IFRyYWRpbm cgSW4gQ29s b3BsYXN0IF NoYXJlcyBC eSBCb2FyZC BNZW1iZXJz LCBFeGVjdX RpdmVzIE9y IEFzc29jaW F0ZWQgUGVy c29ucw== UGxlYXNlIH NlZSBlbmNs b3NlZCBwZG YuIGF0dGFj aG1lbnQgMD YwMzIwMjRf dHJhZGluZ1 9pbl9zaGFy ZXNfa3Zp

📰 Browse additional press releases for Coloplast!

🔓 Unlock our free guide: "The Checklist Value Investor — A Smarter Way to Pick Stocks"

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.